Rescue therapy for early antibody mediated rejection with a proteasome inhibitor: a case report.
Department of Pharmacy, University of Maryland Medical Center, Baltimore, Maryland, USA.
Wana
W
Manitpisitkul
Nikita
N
Wilson
Matthew
M
Cooper
Cheryle
C
Gurk-Turner
Heather
H
Hurley
Flavia
F
Rasetto
Debra
D
KuKuruga
Rolf N
RN
Barth
Benjamin
B
Philosophe
D000328:Adult; D000961:Antilymphocyte Serum / Q000627:therapeutic use; D001897:Boronic Acids / Q000627:therapeutic use*; D000069286:Bortezomib; D003404:Creatinine / Q000097:blood*; D003922:Diabetes Mellitus, Type 1 / Q000601:surgery; D003928:Diabetic Nephropathies / Q000601:surgery; D004231:Diuresis; D006084:Graft Rejection / Q000188:drug therapy* / Q000276:immunology; D006680:HLA Antigens / Q000276:immunology*; D006650:Histocompatibility Testing; D006801:Humans; D007518:Isoantibodies / Q000276:immunology*; D007676:Kidney Failure, Chronic / Q000209:etiology / Q000601:surgery; D016030:Kidney Transplantation / Q000276:immunology*; D008297:Male; D016035:Pancreas Transplantation / Q000276:immunology*; D010956:Plasmapheresis; D011480:Protease Inhibitors / Q000627:therapeutic use*; D011719:Pyrazines / Q000627:therapeutic use*; D006435:Renal Dialysis; D012086:Reoperation; D014019:Tissue Donors; D016896:Treatment Outcome
D000961:Antilymphocyte Serum; D001897:Boronic Acids; D006680:HLA Antigens; D007518:Isoantibodies; D011480:Protease Inhibitors; D011719:Pyrazines; D000069286:Bortezomib; D003404:Creatinine